CLYM
Climb Bio
CLYM
CLYM
71 hedge funds and large institutions have $278M invested in Climb Bio in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
86.25% less ownership
Funds ownership: 167.76% → 81.52% (-86%)
Holders
71
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.56M | |
| 2 | +$6.1M | |
| 3 | +$3.71M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.42M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.01M |
Top Sellers
| 1 | -$8.83M | |
| 2 | -$4.77M | |
| 3 | -$3.32M | |
| 4 |
Walleye Capital
New York
|
-$1.4M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$869K |